VASSOL, INC.

Vassol, Inc. develops NOVA (Noninvasive Optimal Vessel Analysis), an advanced 3D blood flow analytics and imaging software platform for quantitative hemodynamic analysis of cerebral vasculature. NOVA integrates with standard MRI systems—specifically Time-of-Flight MRA and 2D phase-contrast magnetic resonance imaging—to generate three-dimensional vascular models and quantify intracranial blood flow without contrast agents or radiation exposure. The platform is vendor-neutral, PACS-compatible, and features automated processing with patented algorithms for perpendicular scan plane prescription. Clinically validated over 20+ years, NOVA serves neuroradiologists and stroke specialists for diagnosis, treatment planning, and post-intervention assessment of cerebrovascular conditions including carotid stenosis, vertebrobasilar disease, arterial dissection, aneurysm management, and moyamoya disease. An NIH study demonstrated NOVA qMRA® as a robust, independent predictor of recurrent stroke risk.